Excellent talk by Dr. Ali Amidi on cognitive dysfunction in cancer survivors #ECRS2018

YES! Book the whole day/night off because this is going to be epic! The most exercise oncology context ever presented at one time (*I think) & some of the best of the best established and upcoming researchers. Did we mention 19 hours of content!! #ExOncTC ExOnc TC

Very excited to participate and present at #ExOncTC next week.

Great work from G5 highlighting the inverse research law - Clinical research tends to take place most in areas where the clinical need is least.

Published Ahead-of-Print: Development and Evaluation of the Breast Cancer Online Rehabilitation (BRECOR) Program for Self-managed Upper-Body Rehabilitation for Women With Breast Cancer. ow.ly/QqBQ30n9CnQ #CancerRehab #OncologyRehab

Tomorrow's episode is incredible, simply put. I had not one, but TWO amazing guests who are really shaping how we treat patients in the oncology space, & we discuss how their work is more important than ever during COVID. GET READY! #oncoPT #cancerrehab

Last week on our #CCSRCrounds we had Bolette Skjødt Rafn join us and present: Prospective surveillance for cancer-related Lymphedema: How to improve reach of and access to services. If you missed it and want to learn more, check it out! youtu.be/VecX3V6etqE

🔥HOT OFF THE PRESS🔥 Prognostic Markers of Overall Survival in Cancer Patients Attending a Cachexia Support Service: An Evaluation of Clinically Assessed Physical Function, Malnutrition and Inflammatory Status #CancerRehab Dr Prue Cormie Kelcey Bland, PhD

First day as an assist prof Western University Is it normal to be excited and nervous at the same time? Asking for a friend……

Snart afholdes ECRS 2022 - et symposium om livet med kræft for klinikere, forskere og administratorer - som CASTLE arrangerer med forskere fra Kræftens Bekæmpelses Forskningscenter, støttet af Acta Oncologica. I kan stadig tilmelde jer! Bedre Viden om Senfølger linkedin.com/feed/update/ur…

Thanks to IPOS 2022 in Toronto for the opportunity to share my work on lymphedema surveillance. #castle_research #IPOS2022 #trygfonden

Hvem er CASTLE og hvad forsker vi i? Vi fortsætter rækken af portrætter af forskerne på CASTLE. Læs med på Linkedin! Denne gang om Bolette Skjødt Rafn linkedin.com/feed/update/ur…

Important update on evidence base and first(!) Danish clinical guidelines for monitoring and treatment of lymphedema after breast cancer with DBCG presented by Bolette Skjødt Rafn at Bedre Viden om Senfølger late effects seminar today. PROTECTtrial funded by @trygfonden will inform guideline-update

The program of the 𝟑𝐫𝐝 𝐈𝐂𝐏𝐓𝐎 is now 95% complete! The program on September 14 👇 npi.nl/images/bestand… The program on September 15 👇 npi.nl/images/bestand… Register as Early Bird before May 1 with a discount! 👇 npi.nl/ICPTO #ICPTO2023 #oncology